On April 21, 2024, Paragon’s senior fellow Theo Merkel was quoted in AP News article “Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut.”
From the article:
Theo Merkel, senior fellow at the conservative Paragon Health Institute, countered that the insulin price cut an example of “policies written to fit the talking points other than the other way around.”
Merkel, who was a Trump White House adviser on health policy, said manufacturers that have long made insulin prefer caps on how much the insured pay because it gives them more leverage to secure higher prices from insurance companies.
